Lactated Ringer’s Injection Supply (Pharmaceutical Product Manufacturing)

The contract pertains to the supply of Lactated Ringer’s Injection in 1000mL volumes, manufactured to meet stringent USP, FDA, and DLA standards, ensuring compliance with federal pharmaceutical and military medical requirements. This is a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with performance specifically tied to Dyess Air Force Base, Texas, ZIP 79607-1720. The solicitation is classified under NAICS code 325412, which corresponds to pharmaceutical and botanical product manufacturing, indicating the production must align with pharmaceutical-grade quality controls and good manufacturing practices. The opportunity was posted on July 26, 2026, with a response deadline of August 3, 2026, leaving a narrow window for interested parties to submit proposals. All deliverables must satisfy exacting specifications to support military medical readiness and logistical needs, with no set-aside provisions specified for small business or other categories. The contract’s administration is managed through the DIBBS portal, and successful bidders are expected to provide consistent, high-volume production with strict adherence to regulatory and traceability requirements.